New investigational compound targets pancreatic cancer cells
Wednesday, September 15, 2010 - 12:14
in Health & Medicine
A new investigational drug designed to penetrate and attack pancreatic cancer cells has been administered to a patient for the first time ever at the Virginia G. Piper Cancer Center at Scottsdale Healthcare.